Journal News

A collaboration to study host immunity in plants and animals

Nuala Del Piccolo
July 22, 2021

Almost a decade ago, Ralph Panstruga and Jürgen Bernhagen served together on a student’s thesis committee at Rheinisch-Westfälische Technische Hochschule Aachen, a university in Germany. At first glance, Panstruga, a molecular botanist, and Bernhagen, a biochemist in cardiovascular medicine, would seem to have little in common. However, they discovered a shared interest — host immunity — while chatting over coffee after the student’s presentation.

Immunity-445x453.jpg
Jelena Milic / Ludwig Maximilian University
The human chemokine MIF and its plant homolog MDL (depicted as crystal structures) regulate host immunity in humans (left) and Arabidopsis thaliana (right), respectively.

Bernhagen told Panstruga about his research into macrophage migration inhibitory factor, or MIF, a noncanonical cytokine and chemokine that regulates innate immunity and is involved in inflammatory and cardiovascular diseases. Evolutionarily conserved, MIF was incompletely characterized at the time.

“Jürgen told me that he’d heard anecdotes that MIF-like chemokines should also exist in plants, which I couldn’t believe, because chemokines are known to be animal-specific signaling molecules with dedicated receptors and signaling cascades,” Panstruga said. “They were, in my view, unlikely to be present in plants.”

Nonetheless, Panstruga returned to his office and did a computer search that identified related biomolecules based on sequence similarity. He found that Bernhagen was right: Plants have three homologs to MIF known as MIF/D-dopachrome tautomerase–like, or MDL, proteins. However, plants lack cognate receptors, so the scientists wondered about the role of MDL in plants.

Panstruga and Bernhagen began working together to characterize MIF and MDL in the animal and plant kingdoms. “I’ve learned over the years that although the types of immune systems in plants and humans are really significantly different, there are some joint principles that have obviously developed over millions of years,” Bernhagen said.

Bernhagen moved to Ludwig Maximilians University in 2015, but their collaboration continued. Their most recent study, published in the Journal of Biological Chemistry, characterizes the biochemical and biological activity of MDL in Arabidopsis thaliana, a plant from the mustard family and Panstruga’s favorite experimental model system.

The paper begins with a simple question: Where are MDLs located? Most human chemokines are secreted from cells; however, MIFs can be found both inside and outside the cell. Bernhagen and Panstruga’s recent study shows that MDLs are inside cells. This is consistent with the hypothesis that MIF-like cytokines were originally intracellular proteins that evolved to gain secondary functions outside the cell.

Next, the research team deleted the genes coding for MDL from A. thaliana and exposed both mutant and wild-type plants to common pathogens. Mutant plants were more resistant than wild-type to bacterial infections. A targeted metabolite screening failed to identify a mechanistic explanation for this, a gap the researchers plan to address in future work.

The team plans to continue studying host immunity through characterization of MIF and MDL. “The mere comparison of plant protein structure and functions with human proteins — we call this structure-activity relationships — can tell us about which amino acids are important and inform design of drugs against the human protein,” Bernhagen said.

“We learned a lot from each other regarding possibilities and limitations of our experimental systems,” Panstruga said, “and how each can be used to address questions that are not so easy to address in the other system. For example, in plants we can easily generate transgenic lines; this would not be so straightforward in mice.”

The two are eager for the post-pandemic return to campus. “We started working together after a chance meeting at a student’s committee meeting,” Panstruga said. “These little chats are important idea generators in science,” Bernhagen said.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nuala Del Piccolo

Nuala Del Piccolo is a scientific writer at Imperial College London. She earned her B.S. in biomedical engineering and Ph.D. in materials science at Johns Hopkins University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

New mass spectrometry tool accurately identifies bacteria
Journal News

New mass spectrometry tool accurately identifies bacteria

April 30, 2025

Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Journal News

New tool matches microbial and metabolic metaproteomic data

April 30, 2025

Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Interview

Meet Paul Shapiro

April 29, 2025

Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.

CRISPR epigenome editor offers potential gene therapies
News

CRISPR epigenome editor offers potential gene therapies

April 25, 2025

Scientists from the University of California, Berkeley, created a system to modify the methylation patterns in neurons. They presented their findings at ASBMB 2025.

Finding a symphony among complex molecules
Profile

Finding a symphony among complex molecules

April 23, 2025

MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

E-cigarettes drive irreversible lung damage via free radicals
Journal News

E-cigarettes drive irreversible lung damage via free radicals

April 17, 2025

E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.